BridgeMD
New treatment option for Suicide Ideation
Official title A New Clinical Model for the Engagement of Latinx Youth With Suicidal Behavior
ClinicalTrials.gov ID: NCT06882798
What this study is testing
- What it's testing
- This study will test a model of providing treatment to Latinx/Hispanic youth, who experience suicidal thoughts and behavior, and their caregivers. An affirmative and culturally relevant treatment will be provided to all youth and half of the families will be assigned to the additional support of a community health worker (CHW).
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 12 to 18
You may be able to join if
- Latinx, defined as have been born in a Latin country or having at least one biological parent, grandparent or an ancestor that was born in a Latin...
- Severe Suicidal Ideation (SI), defined as one of the following:
- SIQ-JR \> 22 or endorsing any critical items (2, 3, 4, 7, 8, 9) with at least "about 1x/month"
- CDI-II \> 15 and endorsing "I think about killing myself but would not do it" OR "I think about killing myself."
- PHQ-9 \> 10 \& endorsing the item "Thoughts that you would be better off dead, or of hurting yourself in some way" with a frequency of "several days"...
You likely can't join if
- Participants will be referred to a different treatment program if their main clinical complaint is any of the following:
- Behavioral (e.g., conduct disorder, or substance use disorder)
- An eating disorder
- Obsessive-compulsive disorder
- A developmental issue (e.g., speech, occupational, families looking for assessments, treatment for autism) or a significant cognitive delay that may...
See the full eligibility criteria
- Latinx, defined as have been born in a Latin country or having at least one biological parent, grandparent or an ancestor that was born in a Latin country
- Severe Suicidal Ideation (SI), defined as one of the following:
- SIQ-JR \> 22 or endorsing any critical items (2, 3, 4, 7, 8, 9) with at least "about 1x/month"
- CDI-II \> 15 and endorsing "I think about killing myself but would not do it" OR "I think about killing myself."
- PHQ-9 \> 10 \& endorsing the item "Thoughts that you would be better off dead, or of hurting yourself in some way" with a frequency of "several days" or greater or endorsing the item "Has there been a time in the past...
- Suicidal crisis within the past 12 months
- Caregivers and adolescents fluent in Spanish or English language and legal guardian willing to participate
- Participants will be referred to a different treatment program if their main clinical complaint is any of the following:
- Behavioral (e.g., conduct disorder, or substance use disorder)
- An eating disorder
- Obsessive-compulsive disorder
- A developmental issue (e.g., speech, occupational, families looking for assessments, treatment for autism) or a significant cognitive delay that may require specialized treatment adjustments.
The study team makes the final eligibility decision.
Where it's taking place
- Providence, Rhode Island, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 12 years to 18 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Providence, Rhode Island, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.